Cargando…
An Erg11 lanosterol 14-α-demethylase-Arv1 complex is required for Candida albicans virulence
Azole resistant fungal infections remain a health problem for the immune compromised. Current therapies are limited due to rises in new resistance mechanisms. Therefore, it is important to identify new drug targets for drug discovery and novel therapeutics. Arv1 (are1 are2 required for viability 1)...
Autores principales: | Villasmil, Michelle L., Barbosa, Antonio Daniel, Cunningham, Jessie Lee, Siniossoglou, Symeon, Nickels, Joseph T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367482/ https://www.ncbi.nlm.nih.gov/pubmed/32678853 http://dx.doi.org/10.1371/journal.pone.0235746 |
Ejemplares similares
-
Computational insights into fluconazole resistance by the suspected mutations in lanosterol 14α-demethylase (Erg11p) of Candida albicans
por: Prakash, Sagunthala Murugesan Udaya, et al.
Publicado: (2020) -
Analysis of the ergosterol biosynthesis pathway cloning, molecular characterization and phylogeny of lanosterol 14 α-demethylase (ERG11) gene of Moniliophthora perniciosa
por: de Oliveira Ceita, Geruza, et al.
Publicado: (2014) -
Structural Insights into the Azole Resistance of the Candida albicans Darlington Strain Using Saccharomyces cerevisiae Lanosterol 14α-Demethylase as a Surrogate
por: Graham, Danyon O., et al.
Publicado: (2021) -
Oxidation of Isodrimeninol with PCC Yields Drimane Derivatives with Activity against Candida Yeast by Inhibition of Lanosterol 14-Alpha Demethylase
por: Marin, Victor, et al.
Publicado: (2020) -
Identification of 1, 2, 4-Triazine and Its Derivatives Against Lanosterol 14-Demethylase (CYP51) Property of Candida albicans: Influence on the Development of New Antifungal Therapeutic Strategies
por: Verma, Abhishek Kumar, et al.
Publicado: (2022)